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In the present study we present the conditions oﬀered to biotechnology development in Tunisia and we compare three main biotech-
nology applications which raise ethical and health problems: organ transplant, assisted reproductive techniques, and genetically mod-
iﬁed organisms. We try to identify factors that have allowed success of the ﬁrst two applications and failure of the latter. Conditions
oﬀered to biotechnology in other African countries are also discussed.
INTRODUCTION
For biotechnology development, some conditions are
required but are not always provided at the adequate level
in each country. These conditions include:
(1) the role of diﬀerent actors such as scientists, edu-
cators, journalists, politicians, and economic part-
ners;
(2) the existence of specialized structures concerned
with biotechnology (research, training, coordina-
tion, and supervision structures);
(3) the functioning of democratic mechanisms which
enablecivilsocietytoactitswill(ethicscommittees,
laws regulating biotechnology, monitoring struc-
tures, and technological means).
Our purpose is to evaluate to which extent these
conditions are oﬀered to biotechnology development in
Tunisiaandtocomparetheattitudestowardsandthecon-
ditions oﬀered to biotechnology development in Tunisia
through three examples: organ transplant (OT), assisted
reproductive techniques (ART), and genetically modi-
ﬁed organisms (GMOs), in order to identify the factors
that have allowed success of the ﬁrst two applications
and failure of the latter. In practice, the OT, ART, and
GMOs are the main biotechnology applications which
raised public interest which concerns ethical problems in
Tunisia.
THE EXAMPLES OF THREE BIOTECHNOLOGY
APPLICATIONS IN TUNISIA
Organtransplant
Conditions oﬀered for OT development concern in-
formation, specialized structures, and legislation. Good
level of information is provided by radio and TV pro-
grams and by papers in the local press on organ dona-
tion. A National Day of Organ Donation Awareness has
been instituted. Technological structures consist in a Na-
tional Center for Bone Marrow transplant, a bank for tis-
suesandeyes,theBloodTransfusionNationalCenter,and
immunology laboratories (HLA typing). The last creation
in June 1995 is the National Center for Organs Transplan-
tation Promotion (NCOTP). The aims of this centre are
increasing awareness for organ donation, establishing a
waiting list of patients for OT, ensuring transparency and
safety of OT, training of medical and paramedical staﬀ,
training and coordination between medical teams. With
regard to legislation, two laws are particularly in favour of
OT: the law 91-22 created in March 1991 and regulating
OT [1] and the law on the “donor mention” registered on
the National Identity Card of the donor [2]. The spirit of
these laws was to promote organ donation (Table 1).
For OT issues, the High Islamic Council (HIC) has
published its academic resolution authorizing OT [3,
4]. Tunisia was the ﬁrst African country to set up a
National Medical Ethics Committee (NMEC). Tunisia’s
NMEC is rather in favour of OT [5]. Statistics of the year2004:3 (2004) People Reactions to Biotechnologies 125
Table 1. The main points of the two laws on organ transplantation (OT) in Tunisia.
(1) The law 91-22 created in March 1991 and regulating organ transplant
Art.3. It is allowed to remove an organ from a human corpse for therapeutic or scientiﬁc purposes unless there is objection
from the dead person while alive or after death from the entitled individuals as mentioned in the following order: the
children, the father, the mother, the partner, the brothers and sisters and tutor.
Art.8. Donor should show consent for organ donation before the court. A copy of his consent will be delivered to all the
authorized hospitals to practice organs transplant.
Art.9. Donor’s consent could be withdrawn by the donor before the operation without formality.
Art.15. No removal for therapeutic purposes could be done without the statement of death (by two physicians other than
those who will realize removal and organs transplant).
(2) The law 99-18 created in March 1999 relative to the “donor mention” registered on National Identity Card of the donor
The National Identity Card could carry a mention “Donor” which conﬁrms the agreement to make human organ donation
after death. This agreement could be removed through a registered document of the giving up.
Table 2. Some recommendations of the Tunisia’s National Medical Ethics Committee with regard to the assisted reproductive tech-
niques (ART).
(1) Absolute necessity to respect the religious, philosophical and ethical principles of the Tunisian society (the respect of life
and the respect of ﬁliation).
(2) ART must be allowed only for legitimate couples and not to single women.
(3) The couple must be consent and informed of the risk to take (eg, ovarian stimulation, extra-uterine pregnancy).
(4) The preserved embryo should not be kept beyond the fertility period of the couple or the death of one partner.
(5) Necessity to establish clear criteria concerning the conditions of practice of ART (competent clinicians and biologists,
medical control and transparency in the statistics).
Table 3. The main points of the law relative to the assisted reproductive techniques (ART) in Tunisia.
The law 01-93 created in August 2001 and regulating ART
Art.4. There is no way to ART except only for a married and alive couple through gametes that should necessarily be coming
from them and for the couple to be at a reproducing age.
Art.9. It is forbidden to get embryos through the fecundation in vitro or other techniques for study, research or experimen-
tation.
Art.11. Gametes or embryos could be preserved only for therapeutic purposes to help the couple to procreate and after a
written demand from the couple.
Art.14. Gametes or embryos donation is forbidden in the ART.
Art.15. It is forbidden to use the womb (womb-leasing) of another women to allow the embryo development.
2000, in authorized public hospitals, permit to record the
realization of 43 transplantations (kidney: 39; heart: 1;
and liver: 3) and 626 grafts (cornea: 578 and marrow: 50)
(Activity report of National Center for Organs Transplan-
tation Promotion, Tunisia, 2001).
AssistedReproductiveTechniques
The second technology which is much in demand is
the ART. A percentage of 10%–15% of Tunisian couples
are concerned, with 6000 to 8000 candidates for ART per
year. With regard to the success rate, it was about 7%–
20%. The available methods proposed to couples suﬀer-
ing from infertility are artiﬁcial insemination, in vitro fer-
tilization, and the microinjection technique. The in vitro
fertilization (IVF) is available since 1991 in private and in
public hospitals and many hundreds of such operations
a r er e a l i z e de a c hy e a r .T h em a j o rb r a k ei nt h eu s eo ft h e s e
technologies is the cost which is very expensive (about
$2000 to $3000). In a study performed in another African
country,itwasfoundthatoneoutofthirteenpatientswho
were referred to ART centres was able to achieve her ob-
jective of motherhood [6].
At the legislative level, there was a lack of a law reg-
ulating ART until July 2001. At this period the NMEC
gave some rules to conduct ART that take into account
the Islamic viewpoint (Table 2). Recently, since August
2001, the law no 01-93, published in [7], strictly con-
trols ART (Table 3). As the law was inspired by the HIC
and the NMEC opinions on ART, there is no tension be-
tween the Islamic viewpoint and the secular one. Con-
sidering the diﬃculty to obtain gametes from a donor
other than the partner, some couples go abroad, often
to Europe, to beneﬁt from the IVF technique or the
artiﬁcial insemination (procreative tourism). Historical
and geographical reasons made Europe the ﬁrst desti-
nation for North African couples while the US centres126 F. Tebourski and A. Ben Ammar-Elgaaied 2004:3 (2004)
are preferred by Egyptians and Saudi patients (Center for
Surrogate Parenting and Egg Donation Inc, Encino, Calif,
http://www.creatingfamilies.com). With regard to the use
of embryos created by IVF, which are supernumerary,
the law 01-93 (Table 3) as well as the NMEC in Tunisia
(Table 2) have stated their opposition to all experimenta-
tion on the embryo which is regarded as a “potential per-
son” (National Medical Ethics Committee, Opinion No.
1, Tunisia, 12 December 1996). In the French law, super-
numerary embryos could be destroyed but could also be
given to another couple who fulﬁls some conditions [8].
Swiss law also permits embryos donation and the child
could have access to data related to the sperm donor [9].
GeneticallyModiﬁedOrganisms
Despite years of deployment of genetically modiﬁed
crops (GMCs), there is no evidence of injury to peo-
ple [10]. Public opinion on GMOs, one gene-technology-
based application, varied from the condemnation or the
distrust [11] to the support, the encouragement, and even
the defense [10, 12, 13]. Finally, for others the harmless-
ness of GMOs is real and easy to demonstrate, while the
escapeofgenesfromGMCstonativespeciesisconsidered
inevitable [14, 15, 16]. Many observations and reasons
suggested the importance of building public awareness
and involving the public in the biotechnology develop-
ment process. With regard to general opinion in Tunisia,
no national surveys were done. The only study reporting
public opinion about biotechnology was conducted un-
der our supervision and has aﬀected a population of 700
students (Ben Ameur R. Biologie et ´ ethique: attitudes des
´ etudiants du grand Tunis en mati` e r ed eb i o ´ ethique; un-
published data). The results show that 61% of students
were rather against the consumption of GM food. Inter-
estingly, a clear refusal was recorded with girls (69% ver-
sus 53%) and literary sections, especially philosophical
and sociological sections (84% of refusal attitudes); the
mean refusal in scientiﬁc sections was about 48%. Fur-
thermore it was striking to note poor knowledge score
related to GMOs even among scientiﬁc students (17% of
correct answers versus 2% in literary sections).
In Tunisia, only microorganisms and plants are in-
volved in the gene technology. All experiences are en-
closed in laboratories and research centres and there is no
GMO culture in ﬁelds (ie, ﬁeld-testing). With regard to
animal feeding, corn and soya grains are imported with-
outcertiﬁcation.Asaveryhighpercentage(about80%)of
sailed corn in the world is transgenic, we think that corn
bought in Tunisia is GM. Indeed, until now there was no
procedure control and the country needs great quantity
of corn for animal use. Moreover, there is no research on
GManimalsinTunisiaandoﬃciallythereisnoGM-based
seed or seedling. Probably by application of the famous
precautionary principle, researchers and other actors are
waiting for a clear GMO policy.
A law project on GMO is in progress. The elaboration
of such regulation is delicate and tricky because it must
protect, at the same time, consumers, economy, environ-
ment, and scientiﬁc research. The main points of this law
which have been discussed by diﬀerent experts will be as
follows.
(a) The law will concern GMOs importation, stocking,
and transport.
(b) The law will not refuse GM products but will spec-
ify and make clear the conditions of importation.
(c) Some repressive measures will be taken to protect
the consumer, to preserve the environment, and to
control economic exchanges.
Since European countries constitute the main economic
partners of Tunisia, one has to notice that the Tunisian
law will take into account the European regulation.
In the same way, the law project will specify the com-
position and the functioning of the new National Com-
mittee of Biosafety and the conditions to produce GMOs.
What is the situation in African countries? The Orga-
nization of African Unity stressed the request of GMOs
approval before its importation. Each GMO must be la-
belled such, and its producers would be responsible in the
eyesofthelaw(zonelibred’OGM,lesmoratoires ` atra v ers
le monde, http://www.infogm.org). In Egypt, GMCs were
foundtobeneﬁtEgyptianfarmersbythereductionofpes-
ticide application. GMCs authorized in this country are
cotton, squash, potato, tomato, and corn [17]. In Kenya, a
GM sweet potato resistant to virus has been introduced.
Bt-maize has also been introduced and assayed against
local stem borer species [18]. Kenya, South Africa, and
Egypt are the ﬁrst African countries that accepted GMOs
testing in ﬁelds. Applications of biodigesters to generate
biogas for lighting and heating are undertook in Ghana.
In Zambia, government bans GM food aid oﬀered by the
US Agency for International Development via the World
Food Program (WFP) [19].
In North Africa (ie, Maghreb), the people’s reactions
are likely to be similar to Tunisian ones because the three
countries (Tunisia, Algeria, and Morocco) have the same
religious considerations and cultural context. However,
political will, specialized structures, and legislation are
rather diﬀerent.
The practice of the ART today in Morocco knows a
fabulous fancy even in the absence of medical coverage
which could help in the repayment of the medical ex-
penses. It is interesting to note that the 15 centres of ART
practising in Morocco are connected with private health-
care centres [20]. With about forty transplants, Morocco
is far behind countries such as Tunisia and Kuwait. The
legislation stays unsuitable and the organs donation is
governed by the “dahir” of 1952, an obsolete text [21].
With regard to Morocco’s position to GMOs, and in ap-
plication of the principle of precaution, a circular was es-
tablished in August 1999 which forbids the introduction,
on the national territory, of products and food prepa-
rations containing stemming products from GMO. The2004:3 (2004) People Reactions to Biotechnologies 127
Table 4. Comparison of the regulatory situation and current usage for the three technologies OT, ART, and GMO. (+++, ++, and +
are strong, medium, and weak level, resp.)
Biotechnologies OT ART GMO
Achievements
Education-research ++ ++ ++
Information +++ ++ ++
Legislation +++ ++ +
Specialized structures +++ ++ ++
Pressure
will or need
Political will +++ ++ ++
Users pressure and population need ++ +++
Scientists interest ++ + ++
Financial motivation of economic agents ++ ++
External pressure +++
Remarks










Lack of expression of a real
need at the national level
only products allowed are those intended for the animal
diet (eg, corn) and the import of GMOs seeds is forbid-
den. Finally, a project of law related to the control of the
GMOs use and scattering, which aims to protect the hu-
man health, the animal health, and the environment of
possible risks connected to the GMOs, is elaborated at the
level of the Agricultural Department and submitted for
approval [22].
In Algeria, the Order no 30 of October 15th, 2002,
authorizes the taking and the transplantation of or-
gans from corpses. In this country, GMOs import is
banned since December 2000 and the sociocultural con-
text is rather unfavourable to research development
(http://www.infogm.org). Until today, there are no struc-
tures capable of detecting GMOs in the Maghreb coun-
tries. However, Algerian specialists think that the research
in reproductive health is marginalized and very few ef-
forts are granted in this direction [23]. In fact, ART were
recently introduced in Algeria. The ﬁrst step was real-
ized in February 2003, by the birth of the ﬁrst baby by
ART in the private hospital of Boussouf in Constantine
(http://www.1sante.com).
CONCLUSION AND DISCUSSION
The conditions oﬀered in Tunisia to each of the 3
biotechnology examples presented above are diﬀerent.
ForOT,wecannotethatitsdevelopmentisensuredby
wide information as a result of a legislation in its favour,
the existence of specialized structures, and a clear polit-
ical will as a decisive factor of success. An economical
reason is also behind this will. In fact, developing OT at
the national level allows the formation of skilled person-
nel and restricts expenditure. Furthermore, OT consti-
tutesaresponsetoarealneed.Becausethekidneydiseases
are frequent in the country, the ﬁrst transplantation in
Tunisia was kidney transplant.
In the case of the ART, the strong point in favour of its
development is users pressure and population need. The
ART is supported in Tunisia by a strong demand at the
population level but it is limited by religious considera-
tions (Table 4). In fact, the Islamic religion, by prohibit-
ing the child adoption, pushes the couple who wants his
“own” child to need ART.
With regard to GMOs, there is a lack of expression of
a real need at the national economic level. Furthermore,
this biotechnology is limited by safety considerations and
the conditions for its development are rather diﬃcult be-
cause decisions were taken at the political level and not at
the individual one. Finally, legislation in favour of GMOs
takes a long time.
Public debate on acceptance of biotechnology var-
ied among countries and among technology’s main ap-
plications. Generally, concerns are about the health, the
food, and the environment. Biotechnology contribution
to the progress of medicine through the last two decades
did not arouse issues. There is an evident perceived po-
tential beneﬁt arising from biotechnology. On the other
hand, in the agricultural ﬁeld, GMOs give rise to quite
a number of concerns. Those pros and cons have argu-
ments and the planet has never been more divided over
a question than on transgenic crops. This situation leads
some organizations to participate in the debate and pro-
pose their viewpoints. The United Nations Development
Programme (UNDP), for example, judges that develop-
ment perspectives oﬀered by GMOs require strong na-
tional policies with clear regulations to ensure that this
technology does not destabilize development (Making
new technologies work for human development. Annual
report, UNDP, USA, July 2001). As for the International128 F. Tebourski and A. Ben Ammar-Elgaaied 2004:3 (2004)
Service for National Agricultural Research (ISNAR), the
government should not act hastily, but should rather ap-
proachtheissueslowlyandcarefullytoallowtimetostudy
the full implications of the new technology (ISNAR An-
nual report 1998, April 2000). Finally, the African Agency
of Biotechnology (AAB) encourages the production, the
distribution, and the commercialization of biotechnology
products (AAB, http://www.aab.org.dz/francais.htm).
If we limit the analysis to the Tunisian country, it
would be interesting to express the following recommen-
dations.
(i) Importance of communication. We believed that
communication is important to support biotechnology
for GMOs. Our study has demonstrated a lack of infor-
mation among public, even the educated people. Thus, a
high percentage of Tunisian students never heard about
transgenic food. It is worthwhile to notice that in Tunisia,
although biotechnology is well accepted in the medical
ﬁeld,theactualconditionsdonotseemtobefavourableto
GMOs because of precisely, a lack of information. Scien-
tists and the mass media would ﬁnd the appropriate way
to communicate with the public. They should inform the
nonspecialists on stakes and help the society to take ad-
vantage of the biotechnology advances [24]. Political and
ﬁnancial measures should be taken to encourage the dis-
semination of scientiﬁc and technological information.
Concretely, scientiﬁc and medical associations, the “City
of Sciences,” and the journalists could play this role. The
role of these actors is to report the biotechnology facts
as well as to present the issues and the expected beneﬁts.
Thus, the public will be able to judge and to separate be-
tween what is factual from what is speculative. What we
need is the establishment of a balanced view of biotech-
nology: its risks and its beneﬁcial potential [25].
(ii) Establishing and enforcing rules and regulations on
biotechnology. Our analysis has shown that in Tunisia,
biotechnology supported by law and regulations (ie, ART
and OT) is more accepted than that waiting for a legisla-
tion (ie, GMOs). Moreover, legislation reassures the pub-
lic and the scientists and protects the country’s economi-
cal interests.
(iii) Ethical considerations. It is true that since 1992,
the Tunisian country has been dotted with an ethics com-
mittee but this committee is active rather in medical ﬁelds
andhasneverpublishedopinionsrelatedtoplantbiotech-
nology (ie, GMOs). This problem is important in view of
theissuesrelatedtoGMCs.Webelievethatforasuccessful
policy framework, it is necessary to ﬁrst set up a local na-
tional biotechnology committee of experts, government,
and private sector representatives to overview biotechnol-
ogy activities.
Inconclusion,whensafetyexceedsrisks,intrinsiccon-
siderations are over external pressures and when the po-
litical will and the popular demand go hand in hand, then
the conditions are favourable to the development of a
giventechnology.Inanycase,moreinformation,training,
research,regulation,coordination,democracy,ethics,and
more wisdom can be recommended.
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